Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Axsome Therapeutics (AXSM) Debt Ratio (2022 - 2025)

Axsome Therapeutics' Debt Ratio history spans 4 years, with the latest figure at 0.27 for Q4 2025.

  • For Q4 2025, Debt Ratio fell 18.13% year-over-year to 0.27; the TTM value through Dec 2025 reached 0.27, down 18.13%, while the annual FY2025 figure was 0.27, 18.13% down from the prior year.
  • Debt Ratio for Q4 2025 was 0.27 at Axsome Therapeutics, up from 0.19 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.56 in Q1 2022 and bottomed at 0.19 in Q3 2025.
  • The 4-year median for Debt Ratio is 0.32 (2023), against an average of 0.33.
  • The largest annual shift saw Debt Ratio plummeted 45.61% in 2023 before it increased 13.52% in 2024.
  • A 4-year view of Debt Ratio shows it stood at 0.3 in 2022, then grew by 3.79% to 0.31 in 2023, then rose by 6.01% to 0.33 in 2024, then fell by 18.13% to 0.27 in 2025.
  • Per Business Quant, the three most recent readings for AXSM's Debt Ratio are 0.27 (Q4 2025), 0.19 (Q3 2025), and 0.2 (Q2 2025).